No mutation in the fibroblast-growth-factor receptor-4 (FGFR-4) signalling
pathway has so far been associated with either heritable human diseases or
cancer A new study now implicates N-CAM-FGFR-4 signalling in the regulation
of tumour-cell-matrix adhesion and in the metastatis of pancreatic beta -c
ell tumours.